Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
Settings
KERX Keryx Biopharmaceuticals Inc. daily Stock Chart
KERX [NASD]
Keryx Biopharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.26 Insider Own0.30% Shs Outstand105.18M Perf Week0.57%
Market Cap373.39M Forward P/E- EPS next Y-0.56 Insider Trans5.72% Shs Float103.02M Perf Month-19.68%
Income-125.60M PEG- EPS next Q-0.25 Inst Own84.30% Short Float24.31% Perf Quarter-34.14%
Sales8.50M P/S43.93 EPS this Y-112.10% Inst Trans-1.65% Short Ratio15.07 Perf Half Y-48.10%
Book/sh1.15 P/B3.09 EPS next Y47.70% ROA-78.40% Target Price10.91 Perf Year-70.64%
Cash/sh0.97 P/C3.65 EPS next 5Y- ROE-98.50% 52W Range2.80 - 14.89 Perf YTD-29.70%
Dividend- P/FCF- EPS past 5Y-51.00% ROI-152.40% 52W High-76.16% Beta4.08
Dividend %- Quick Ratio3.60 Sales past 5Y-15.60% Gross Margin37.60% 52W Low26.79% ATR0.36
Employees155 Current Ratio4.80 Sales Q/Q1543.80% Oper. Margin- RSI (14)45.66 Volatility8.46% 11.70%
OptionableYes Debt/Eq0.01 EPS Q/Q23.70% Profit Margin- Rel Volume0.88 Prev Close3.64
ShortableYes LT Debt/Eq0.01 EarningsFeb 25 BMO Payout- Avg Volume1.66M Price3.55
Recom2.60 SMA201.47% SMA50-19.78% SMA200-46.32% Volume1,466,329 Change-2.47%
Oct-05-15Upgrade Morgan Stanley Underweight → Equal-Weight
Sep-09-15Initiated Raymond James Mkt Perform
Sep-03-15Initiated Citigroup Sell
Aug-13-15Initiated Morgan Stanley Underweight $3
Aug-11-15Initiated FBR Capital Mkt Perform $10
Aug-10-15Downgrade ROTH Capital Buy → Neutral $11 → $6
Aug-06-15Reiterated Maxim Group Buy $17 → $11
Jul-23-15Reiterated ROTH Capital Buy $23 → $11
May-06-15Reiterated Mizuho Buy $25 → $21
May-05-15Reiterated ROTH Capital Buy $27 → $23
May-05-15Reiterated Maxim Group Buy $32 → $17
Apr-20-15Reiterated Stifel Buy $19 → $17
Mar-20-15Reiterated Oppenheimer Outperform $22 → $18
Mar-02-15Reiterated Stifel Buy $22 → $19
Feb-27-15Reiterated ROTH Capital Buy $32 → $27
Feb-03-15Reiterated Mizuho Buy $30 → $25
Dec-02-14Reiterated FBR Capital Underperform
Nov-28-14Reiterated Maxim Group Buy $26 → $32
Nov-17-14Reiterated FBR Capital Underperform $14 → $12
Sep-22-14Resumed Oppenheimer Outperform $22
Jan-26-16 03:04PM  Klarman Gives Insight on Keryx Biopharmaceuticals Investment +10.12%
Jan-14-16 09:04AM  Why Keryx Biopharmaceuticals Dropped 64% in 2015 at Motley Fool
Jan-12-16 08:02AM  These Biotech Stocks Could Double in 2016 at Motley Fool
Jan-04-16 01:27PM  Keryx Biopharmaceuticals, Inc. Value Analysis (NASDAQ:KERX) : January 4, 2016
Dec-31-15 08:06AM  Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 31, 2015
Dec-22-15 04:05PM  Keryx Biopharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11 GlobeNewswire -6.88%
Dec-21-15 02:07PM  XBI Recovers from Its Slump +7.99%
Dec-17-15 08:00AM  Technical Briefing on Biotechnology Equities -- Keryx Biopharma, Cytokinetics, Curis, and BioTime Accesswire
Dec-11-15 08:30AM  Equities Lead Investor Sentiment - Research Reports on TriNet Group, Xencor, Keryx Biopharmaceuticals and TeleCommunication Systems Accesswire -9.09%
Dec-10-15 04:39PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and +5.11%
08:00AM  Keryx Announces Appointment of John P. Butler to its Board of Directors GlobeNewswire
Dec-08-15 01:16PM  KERYX BIOPHARMACEUTICALS INC Financials
08:50AM  Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 8, 2015
Dec-05-15 10:50AM  Hedge Funds Are Selling Keryx Biopharmaceuticals (KERX) at Insider Monkey
Dec-01-15 09:05AM  Keryx Biopharmaceuticals Announces Webcast of Presentation at Oppenheimer's 26th Annual Healthcare Conference GlobeNewswire
Nov-21-15 01:56PM  A10 Networks Inc (ATEN) Growing In Popularity Among Top Investors at Insider Monkey
Nov-08-15 12:38PM  Why Keryx Biopharmaceuticals Rallied 40% in October at Motley Fool
Nov-03-15 04:05PM  Keryx Biopharmaceuticals Announces Participation at Two Upcoming Investor Conferences GlobeNewswire +10.88%
Oct-30-15 11:24AM  XBI Fell the Most as the Small-Caps Took a Hit
10:20AM  Keryx Q3 Loss Wider-than-Expected, Auryxia in Focus
Oct-29-15 10:06PM  Edited Transcript of KERX earnings conference call or presentation 29-Oct-15 12:00pm GMT +12.75%
01:57PM  Did Keryx Biopharmaceuticals Inc Finally Turn The Corner? at Motley Fool
08:51AM  Keryx Biopharma reports 3Q loss
08:25AM  Keryx's (KERX) Q3 Loss Wider-Than-Expected
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:31AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:20AM  Keryx reports $4.2M in quarterly revenues, beating expectations at bizjournals.com
07:07AM  Q3 2015 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open
07:00AM  Keryx Biopharmaceuticals Announces Third Quarter 2015 Financial Results GlobeNewswire
Oct-28-15 11:29AM  Trader looks for Keryx to end slide
08:58AM  Should You Buy Keryx (KERX) Ahead of Earnings?
Oct-27-15 04:12PM  Can Keryx (KERX) Surprise Investors This Earnings Season?
03:02PM  AmerisourceBergen (ABC) Q4 Earnings: What to Expect?
Oct-25-15 06:01PM  Why Keryx Biopharmaceuticals Was Obliterated in September at Motley Fool
Oct-23-15 04:00PM  What's in Store for Gilead (GILD) this Earnings Season?
Oct-22-15 08:12AM  Attention Shareholders: Keryx Biopharmaceuticals Due Diligence Report Accesswire
Oct-21-15 04:30PM  Keryx to Raise $125M Through Private Placement of Notes
09:05AM  Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2015 Financial Results on Thursday, October 29, 2015 GlobeNewswire
Oct-20-15 06:26AM  5 Stocks That Could Double In 2016 at Motley Fool -5.15%
Oct-19-15 05:22PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ +12.27%
02:02PM  Four Hot Biotechs Among The Days Big Winners at Insider Monkey
Oct-15-15 05:41PM  Why Keryx Biopharmaceutial Is Up Big Today at Motley Fool +6.42%
12:53PM  Why Are An Indian Automaker and Two Biotech Stocks Leading Todays Gainers? at Insider Monkey
11:10AM  Boston hedge fund hikes the stakes again in battle over drug maker Keryx at bizjournals.com
09:37AM  These 3 Biotechs Have Been Falling Like a Knife in 2015 -- Is 1 Now a Buy? at Motley Fool
07:00AM  Keryx Biopharmaceuticals Announces $125 Million Private Placement of Convertible Senior Notes With The Baupost Group, L.L.C. GlobeNewswire
Oct-14-15 10:57AM  What Happened To Billionaire Seth Klarmans Top Biotech Picks In The Third Quarter? at Insider Monkey
Oct-07-15 08:14AM  Pharmaceutical Sector Due Diligence Report - Searching for Opportunities Among the Bruised Small Cap Market Accesswire +6.92%
Oct-01-15 11:03AM  Keryx Biopharmaceuticals, Inc. Earnings Q2, 2015 -9.38%
Sep-30-15 03:15PM  6 U.S.-Listed Stocks Short Sellers Are Strongly Betting Against
Sep-25-15 12:37PM  Keryx Wins EU Approval for Kidney Disease Drug at Investopedia -8.79%
Sep-24-15 02:38PM  Two Biotech Stocks Have Been Ignoring the Crowd Today and This Metric Says They are Poised to Grow Even Further at Insider Monkey
11:44AM  Keryx Biopharmaceuticals Grabs an Important Approval at Motley Fool
11:11AM  Keryx Biopharmaceuticals (KERX) Stock Jumps on European Regulatory Approval at TheStreet
10:33AM  Mid-Morning Market Update: Markets Tumble; Accenture Tops Q4 Estimates
07:00AM  Keryx Receives European Approval for Fexeric(R) (ferric citrate coordination complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease GlobeNewswire
Sep-23-15 10:01PM  Trending Now: KERX
Sep-18-15 08:44AM  3 Healthcare Stocks That Cost Less Than a Trip to Chipotle at Motley Fool -5.39%
Sep-11-15 05:21PM  Why Shares of Keryx Biopharmaceuticals Dropped Hard in August at Motley Fool
Sep-09-15 08:30AM  Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences GlobeNewswire
Sep-03-15 03:17PM  Why Shares of Keryx Biopharmaceuticals Fell Hard Today at Motley Fool -16.09%
Aug-28-15 05:15PM  3 Battleground Biotech Stocks I Would Avoid at All Costs at Motley Fool
09:57AM  5 Breakout Stocks to Trade for Big Gains at TheStreet
Aug-18-15 02:28PM  Mid-Day Market Update: Tuesday's Top Shorted Stocks
01:48PM  4 Reasons to Sell Keryx Pharmaceuticals at Motley Fool
Aug-13-15 06:19AM  Coverage initiated on Keryx Biopharma by Morgan Stanley -5.88%
Aug-10-15 08:14AM  No Longer A Buy: Roth Capital Downgrades Keryx Biopharma, Slashes Price Target To $6
Aug-08-15 08:10PM  10-Q for Keryx Biopharmaceuticals, Inc. at Company Spotlight
Aug-07-15 06:10AM  Biotech Stock Mailbag: Controversial Stocks Revisited at TheStreet -8.33%
Aug-06-15 06:00PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report -8.92%
02:42PM  Keryx Posts In-Line Loss in Q2, Auryxia in Focus - Analyst Blog
06:19AM  [$$] Keryx Shares Could Triple Despite Slower Sales at Barrons.com
Aug-05-15 03:05PM  Edited Transcript of KERX earnings conference call or presentation 5-Aug-15 12:00pm GMT
01:55PM  Keryx revenue falls short despite support of analysts, Baupost at bizjournals.com
09:05AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
08:29AM  Keryx's (KERX) Q2 Loss in-Line with Estimates - Tale of the Tape
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:18AM  Keryx Biopharma reports 2Q loss
07:07AM  Q2 2015 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open
07:00AM  Keryx Biopharmaceuticals Announces Second Quarter 2015 Financial Results GlobeNewswire
Aug-04-15 07:04PM  Why Keryx Biopharmaceuticals Stock Plunged 18% in July at Motley Fool
03:41PM  5 Reasons to Buy Keryx Pharmaceuticals at Motley Fool
01:50PM  Will Keryx (KERX) Miss Estimates This Earnings Season? - Analyst Blog
Jul-28-15 04:05PM  Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2015 Financial Results on Wednesday, August 5, 2015 GlobeNewswire +5.61%
Jul-27-15 05:22PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
08:00AM  Keryx Biopharmaceuticals Appoints Scott A. Holmes as Chief Financial Officer GlobeNewswire
Jul-24-15 04:16PM  Why Shares of Keryx Biopharmaceuticals Fell Today at Motley Fool -15.33%
07:10AM  Keryx Receives CHMP Positive Opinion for Fexeric(R) (Ferric Citrate Coordination Complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease GlobeNewswire
Jul-16-15 05:50PM  Faruqi & Faruqi, LLP is Investigating Keryx Biopharmaceuticals, Inc. (KERX) on Behalf of its Shareholders PR Newswire
Jul-07-15 07:43AM  Blame Keryx Executives, Not Short Sellers, for Dismal Drug Launch, Sinking Stock at TheStreet
Jul-06-15 07:10AM  How short sellers threaten innovations that could benefit patients at bizjournals.com
Jun-29-15 11:49PM  Edited Transcript of KERX presentation 24-Jun-15 6:30pm GMT
Jun-24-15 05:31PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:45AM  Boston drug company Keryx continues to shake off the haters at bizjournals.com
08:00AM  Keryx Announces Two National Insurance Providers Added Auryxia(TM) to Their Medicare Part D Formularies GlobeNewswire
Jun-17-15 05:02PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-16-15 09:00AM  Keryx Biopharmaceuticals to Present at the JMP Securities Life Sciences Conference 2015 GlobeNewswire
May-27-15 09:10AM  MKM Partners' 4 Health Care Stocks to Sell Before June at TheStreet
May-22-15 07:59PM  Billionaire Klarmans Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF Energy at Insider Monkey
May-12-15 06:32PM  CORRECTING and REPLACING -- Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference GlobeNewswire
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, as well as treats iron deficiency anemia. Auryxia is also used to control serum phosphorus levels in patients with chronic kidney disease on dialysis. The company also has sublicense agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Auryxia in Japan. It also has strategic alliance with Panion & BF Biotech, Inc. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adams BrianVP and General CounselJan 15Sale3.301,3224,36353,132Jan 20 05:05 PM
Adams BrianVP and General CounselJan 06Sale5.163,00415,50154,454Jan 06 09:44 PM
Madison GregPresident and CEOJan 06Sale4.834,26120,581110,820Jan 06 09:43 PM
Madison GregPresident and CEONov 09Sale5.181,6388,485115,081Nov 12 05:00 PM
Holmes Scott AChief Financial OfficerNov 04Buy5.401,3287,17159,742Nov 05 05:01 PM
Holmes Scott AChief Financial OfficerNov 03Buy5.303,67219,45858,414Nov 05 05:01 PM
Adams BrianVP and General CounselOct 15Sale4.011,0114,05457,458Oct 19 05:33 PM
Holmes Scott AChief Financial OfficerAug 21Buy5.725,00028,59054,742Aug 24 06:06 PM
Madison GregPresident and CEOAug 20Buy5.699,98456,759116,719Aug 24 06:10 PM
Neylan John F.Chief Medical OfficerAug 12Buy6.2010,00062,00055,000Aug 14 07:30 AM
Madison GregPresident and CEOAug 10Sale6.071,68310,216106,735Aug 12 07:00 PM
Holmes Scott AChief Financial OfficerJul 31Sale7.872,75821,70549,742Aug 03 07:30 PM
Adams BrianVP and General CounselJul 15Sale9.991,08610,84958,469Jul 17 08:00 PM
Oliviero James F IIIChief Financial OfficerMay 12Option Exercise2.6741,611111,095211,349May 12 07:57 PM
Adams BrianVP and General CounselApr 15Sale12.404,32053,56859,555Apr 17 07:00 PM
BENTSUR RONChief Executive OfficerApr 06Sale11.681,59218,595777,209Apr 08 08:00 PM
Oliviero James F IIIChief Financial OfficerApr 06Sale11.681,87821,935169,738Apr 08 08:01 PM
Madison GregPresident and COOFeb 09Sale10.956,75974,011103,663Feb 10 09:00 PM